This review explores the impact of pharmaceutical industry information and promotional strategies aimed at prescribers, bringing together evidence on how interactions between the pharmaceutical industry and healthcare professionals can influence prescribing decisions, contributing to important conversations around transparency, evidence-informed practice, and the responsible use of medicines. This is an important addition to the evidence base and reflects ongoing efforts to strengthen understanding of the factors that shape healthcare decision-making.